SARS-CoV-2-inactivated vaccine hesitancy and the safety in inflammatory bowel disease patients: a single-center study

BACKGROUND: The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) vaccine is thought to be the most effective preventive method of controlling the coronavirus disease 2019 (COVID-19) epidemic. Some patients with immune-related diseases, including inflammatory bowel disease (IBD) patients,...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yubin, Feng, Jiaming, Duan, Shihao, Yang, Yi, Zhang, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189530/
https://www.ncbi.nlm.nih.gov/pubmed/35706827
http://dx.doi.org/10.1177/17562848221101722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9189530/
https://www.ncbi.nlm.nih.gov/pubmed/35706827
http://dx.doi.org/10.1177/17562848221101722

Ejemplares similares